Pulmonary Tumor Thrombotic Microangiopathy with Administration of Pulmonary Vasodilator Resulting in Clinical Improvement Prior to Final Diagnosis
Open Access
- 30 August 2021
- journal article
- research article
- Published by International Scientific Information, Inc. in The American Journal of Case Reports
- Vol. 22, e933867-1-e933867-5
- https://doi.org/10.12659/ajcr.933867
Abstract
Pulmonary Tumor Thrombotic Microangiopathy with Administration of Pulmonary Vasodilator Resulting in Clinical Improvement Prior to Final Diagnosis - Article abstract #933867Keywords
This publication has 9 references indexed in Scilit:
- Pulmonary tumor thrombotic microangiopathy: a systematic reviewPulmonary Circulation, 2019
- Guidelines for the Treatment of Pulmonary Hypertension (JCS 2017/JPCPHS 2017)Circulation Journal, 2019
- Riociguat for the treatment of pulmonary hypertensionExpert Review of Respiratory Medicine, 2015
- Chemotherapy Use, Performance Status, and Quality of Life at the End of LifeJAMA Oncology, 2015
- Pulmonary hypertension: diagnostic and therapeutic challengesTherapeutics and Clinical Risk Management, 2015
- Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension?European Respiratory Journal, 2015
- Pulmonary Tumor Thrombotic Microangiopathy: A Clinical Analysis of 30 Autopsy CasesInternal Medicine, 2013
- Pulmonary tumor thrombotic microangiopathy caused by gastric cancerAnnals of Thoracic Medicine, 2012
- Soluble Guanylate Cyclase as an Emerging Therapeutic Target in Cardiopulmonary DiseaseJournal of the American College of Cardiology, 2011